Institutional members access full text with Ovid®

Share this article on:

Long-term pediatric ventricular assist device therapy: a case report of 2100+ days of support.

Purkey, Neha J.; Lin, Aileen; Murray, Jenna M.; Gowen, Maryalice; Shuttleworth, Paul; Maeda, Katsuhide; Almond, Christopher S.; Rosenthal, David N.; Chen, Sharon
doi: 10.1097/MAT.0000000000000546
Case Report: PDF Only

Ventricular assist devices (VADs) have been placed as destination therapy in adults for over twenty years1 but have only recently been considered an option in a subset of pediatric patients. A 2016 report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS) revealed only eight pediatric patients implanted as destination therapy.2 We report the case of an adolescent male with Becker Muscular Dystrophy (BMD) who underwent VAD placement in 2011 as bridge to candidacy. He subsequently decided to remain as destination therapy and so far has accrued over 2100 days on VAD support, the longest duration of pediatric VAD support reported in the literature to date.

Copyright (C) 2017 by the American Society for Artificial Internal Organs